vs
安捷伦科技（A）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是安捷伦科技的1.2倍（$2.1B vs $1.8B），安捷伦科技净利率更高（17.0% vs 15.8%，领先1.2%），Roper Technologies同比增速更快（11.3% vs 7.0%），Roper Technologies自由现金流更多（$507.0M vs $175.0M），过去两年Roper Technologies的营收复合增速更高（10.5% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
A vs ROP — 直观对比
营收规模更大
ROP
是对方的1.2倍
$1.8B
营收增速更快
ROP
高出4.3%
7.0%
净利率更高
A
高出1.2%
15.8%
自由现金流更多
ROP
多$332.0M
$175.0M
两年增速更快
ROP
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $2.1B |
| 净利润 | $305.0M | $331.0M |
| 毛利率 | 52.6% | 69.4% |
| 营业利润率 | 19.6% | 27.2% |
| 净利率 | 17.0% | 15.8% |
| 营收同比 | 7.0% | 11.3% |
| 净利润同比 | -4.1% | 53.7% |
| 每股收益（稀释后） | $1.07 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AROP
| Q1 26 | $1.8B | $2.1B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.7B | $1.9B | ||
| Q4 24 | $1.7B | $1.9B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.7B |
净利润AROP
| Q1 26 | $305.0M | $331.0M | ||
| Q4 25 | $434.0M | $428.4M | ||
| Q3 25 | $336.0M | $398.5M | ||
| Q2 25 | $215.0M | $378.3M | ||
| Q1 25 | $318.0M | $331.1M | ||
| Q4 24 | $351.0M | $462.3M | ||
| Q3 24 | $282.0M | $367.9M | ||
| Q2 24 | $308.0M | $337.1M |
毛利率AROP
| Q1 26 | 52.6% | 69.4% | ||
| Q4 25 | 53.2% | 69.5% | ||
| Q3 25 | 51.1% | 69.5% | ||
| Q2 25 | 51.9% | 69.2% | ||
| Q1 25 | 53.5% | 68.7% | ||
| Q4 24 | 53.9% | 68.3% | ||
| Q3 24 | 54.2% | 69.2% | ||
| Q2 24 | 54.4% | 69.5% |
营业利润率AROP
| Q1 26 | 19.6% | 27.2% | ||
| Q4 25 | 23.8% | 28.6% | ||
| Q3 25 | 20.7% | 28.4% | ||
| Q2 25 | 18.0% | 28.2% | ||
| Q1 25 | 22.4% | 27.9% | ||
| Q4 24 | 24.0% | 28.0% | ||
| Q3 24 | 21.1% | 28.1% | ||
| Q2 24 | 23.1% | 28.8% |
净利率AROP
| Q1 26 | 17.0% | 15.8% | ||
| Q4 25 | 23.3% | 20.8% | ||
| Q3 25 | 19.3% | 19.8% | ||
| Q2 25 | 12.9% | 19.5% | ||
| Q1 25 | 18.9% | 17.6% | ||
| Q4 24 | 20.6% | 24.6% | ||
| Q3 24 | 17.9% | 20.8% | ||
| Q2 24 | 19.6% | 19.6% |
每股收益（稀释后）AROP
| Q1 26 | $1.07 | $4.87 | ||
| Q4 25 | $1.53 | $3.97 | ||
| Q3 25 | $1.18 | $3.68 | ||
| Q2 25 | $0.75 | $3.49 | ||
| Q1 25 | $1.11 | $3.06 | ||
| Q4 24 | $1.23 | $4.29 | ||
| Q3 24 | $0.97 | $3.40 | ||
| Q2 24 | $1.05 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $382.9M |
| 总债务越低越好 | $3.0B | $9.7B |
| 股东权益账面价值 | $6.9B | $18.8B |
| 总资产 | $12.8B | $34.6B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资AROP
| Q1 26 | $1.8B | $382.9M | ||
| Q4 25 | $1.8B | $297.4M | ||
| Q3 25 | $1.5B | $320.0M | ||
| Q2 25 | $1.5B | $242.4M | ||
| Q1 25 | $1.5B | $372.8M | ||
| Q4 24 | $1.3B | $188.2M | ||
| Q3 24 | $1.8B | $269.6M | ||
| Q2 24 | $1.7B | $251.5M |
总债务AROP
| Q1 26 | $3.0B | $9.7B | ||
| Q4 25 | $3.0B | $9.3B | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $7.6B | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益AROP
| Q1 26 | $6.9B | $18.8B | ||
| Q4 25 | $6.7B | $19.9B | ||
| Q3 25 | $6.4B | $20.0B | ||
| Q2 25 | $6.1B | $19.6B | ||
| Q1 25 | $6.0B | $19.2B | ||
| Q4 24 | $5.9B | $18.9B | ||
| Q3 24 | $5.9B | $18.5B | ||
| Q2 24 | $6.2B | $18.1B |
总资产AROP
| Q1 26 | $12.8B | $34.6B | ||
| Q4 25 | $12.7B | $34.6B | ||
| Q3 25 | $12.2B | $34.6B | ||
| Q2 25 | $12.2B | $33.2B | ||
| Q1 25 | $11.9B | $31.4B | ||
| Q4 24 | $11.8B | $31.3B | ||
| Q3 24 | $11.0B | $31.6B | ||
| Q2 24 | $10.9B | $29.8B |
负债/权益比AROP
| Q1 26 | 0.44× | 0.52× | ||
| Q4 25 | 0.45× | 0.47× | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | 0.40× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | — |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $507.0M |
| 自由现金流率自由现金流/营收 | 9.7% | 24.2% |
| 资本支出强度资本支出/营收 | 5.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $993.0M | — |
8季度趋势，按日历期对齐
经营现金流AROP
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $738.0M | ||
| Q3 25 | $362.0M | $869.5M | ||
| Q2 25 | $221.0M | $404.1M | ||
| Q1 25 | $431.0M | $528.7M | ||
| Q4 24 | $481.0M | $722.2M | ||
| Q3 24 | $452.0M | $755.4M | ||
| Q2 24 | $333.0M | $384.1M |
自由现金流AROP
| Q1 26 | $175.0M | $507.0M | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
自由现金流率AROP
| Q1 26 | 9.7% | 24.2% | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
资本支出强度AROP
| Q1 26 | 5.2% | 0.5% | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
现金转化率AROP
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.72× | ||
| Q3 25 | 1.08× | 2.18× | ||
| Q2 25 | 1.03× | 1.07× | ||
| Q1 25 | 1.36× | 1.60× | ||
| Q4 24 | 1.37× | 1.56× | ||
| Q3 24 | 1.60× | 2.05× | ||
| Q2 24 | 1.08× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ROP
暂无分部数据
